Forte Biosciences annual meeting elects directors; auditor ratification approved

Forte Biosciences, Inc.

Elected Richard Vincent, Shiv Kapoor, and David Gryska as Class II directors until 2028.
David Gryska received 2,786,414 votes for and 1,313,237 withheld (32% withheld).
Ratified KPMG LLP as independent auditor for FY2025 with 5,285,363 votes for, 2,987 against.
5,288,388 shares represented out of 6,583,382 outstanding (80.3% quorum).

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.